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Abstract
Background: Because individuals with HIV/AIDS often have complex medical and social needs,
the impact of housing status on medical service utilization is difficult to isolate from the impact of
conditions that may worsen during periods of homelessness such as depression and substance
abuse. We examine whether episodes of homelessness are independently associated with
suboptimal medical utilization even when accounting for concurrent addiction severity and
depression.
Methods: We used data from a 30-month cohort of patients with HIV/AIDS and alcohol problems.
Housing status, utilization (ambulatory visits, emergency department (ED) visits, and
hospitalizations) and other features were assessed with standardized research interviews at 6-
month intervals. Multivariable longitudinal regression models calculated incidence rate ratios (IRR)
comparing utilization rates during 6-month intervals (homeless versus housed). Additional models
assessed whether addiction severity and depressive symptoms could account for utilization
differences.
Results: Of the 349 subjects, 139 (39%) reported homelessness at least once during the study
period; among these subjects, the median number of nights homeless per 6-month interview period
was 30. Homelessness was associated with higher ED utilization (IRR = 2.17; 95% CI = 1.72–2.74)
and hospitalizations (IRR = 2.30; 1.70–3.12), despite no difference in ambulatory care utilization
(IRR = 1.09; 0.89–1.33). These associations were attenuated but remained significant when
adjusting for addiction severity and depressive symptoms.
Conclusion: In patients with HIV/AIDS and alcohol problems, efforts to improve housing stability
may help to mitigate intensive medical utilization patterns.
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Background
Indigent populations are disproportionately affected by
HIV infection. The prevalence of HIV infection is 5 to 9
times higher in urban poor populations than the general
population [1,2]. Approximately one half of individuals
with HIV/AIDS who receive services funded by the Ryan
White Comprehensive AIDS Resources Emergency Act live
below the Federal Poverty Level [3]. In the HIV Cost and
Utilization Study (HCSUS), 46% reported an annual
income less than $10,000 [4].
In part due to the overlap between poverty and unstable
housing, many individuals with HIV infection experience
homelessness. About one third of HCSUS participants
reported a need for housing services with 39% of those
needing housing services unable to access these services
[5]. Among HIV-infected veterans, 32% have been home-
less at some point in their lives [6] compared to 7.4% of
the general population [7]. Prevalence estimates of home-
lessness in persons with HIV range from 6% to 27%
among a New York State Medicaid population [8], clients
at federally funded HIV clinics [3], and adults with sub-
stance abuse disorders [9]. In comparison, 3.1% of the
general population sampled by random digit dialing has
been homeless in the past 5 years [7].
Homelessness among HIV-infected persons is associated
with a lower likelihood of receiving prophylaxis for
opportunistic infections [10] and highly active antiretro-
viral therapy [11] as well as higher mortality rates [12].
Reduced access to effective therapies occurs in the context
of higher rates of emergency department (ED) utilization
[9,13] and hospital admissions [8,9]. Because indigent
patients with HIV/AIDS often have complex medical and
social needs, the impact of housing status is difficult to
isolate from other conditions that increase the risk of
homelessness and affect access to care such as addictions
[9,14-16] and depression [17-19]. Previous studies on the
impact of housing status on utilization among individuals
with HIV infection have modeled homelessness as a per-
manent condition despite evidence that most individuals
who are homeless have intermittent periods of stable
housing [20]. In this study of the relationship between
homelessness and health care utilization, we elected to
treat homelessness as a state that could vary over time.
To the extent that homelessness might be associated with
distinct patterns of health service utilization among HIV-
infected individuals, relevant policy decisions ultimately
must pivot upon clarification of which particular prob-
lems need targeting. That is, high cost utilization patterns
could reflect worse HIV progression, greater addiction
severity, impaired access to a usual source of ambulatory
care, or potentially the impact of homelessness itself. Each
of these associations might arguably call for somewhat
different policy responses. Hence, a secondary interest of
this study is to disentangle, in an exploratory way, contrib-
uting factors to utilization patterns.
Among HIV-infected individuals, alcohol misuse demar-
cates a group at special risk for adverse outcomes [6]
including housing instability. We therefore used data
from a cohort study of HIV-infected individuals with alco-
hol problems to examine the hypothesis that HIV-infected
persons would utilize less ambulatory care and more
emergency department and inpatient care during periods
with an episode of homelessness, compared to periods
without homelessness. Furthermore we set out to explore
the independent contributions of relevant variables
(addiction severity and depressive symptoms) with the
expectation that these variables would substantially atten-
uate and potentially explain any apparent association
between homelessness and service utilization patterns in
this sample of HIV-infected persons with a history of alco-
hol problems.
Methods
Study population
We analyzed data from the HIV-Alcohol Longitudinal
Cohort (HIV-ALC) study. The primary purpose of the
HIV-ALC study was to prospectively examine the impact
of alcohol use on HIV disease progression. Subjects in the
HIV-ALC cohort receiving antiretroviral therapy were eli-
gible to participate in a randomized controlled trial of an
antiretroviral adherence intervention. A description of the
patients in the HIV-ALC cohort [21] as well as the antiret-
roviral adherence intervention has been previously pub-
lished [22]. Briefly, eligibility for the HIV-ALC study
included endorsement of two or more positive responses
to the CAGE questionnaire [23] or a physician co-investi-
gator clinical diagnosis of lifetime alcohol abuse or
dependence. The eligibility criteria of a history of alcohol
problems was determined by the CAGE questionnaire in
313/349 (90%) of subjects, and based on clinical assess-
ment in 36/349 (10%) of subjects. Other entry criteria
included the following: fluency in English or Spanish,
Mini-Mental State Examination score greater or equal to
21 [24], and no plans to move from the Boston area in the
two years following the baseline assessment. All subjects
had HIV infection confirmed either as part of clinical care
or as part of the study. Subjects were recruited from the
following sites: 56% from the Boston Medical Center HIV
Diagnostic Evaluation Unit [25]; 17% from posted flyers;
13% from Boston Medical Center Primary Care Clinic; 5%
from a medical respite facility for homeless persons; 4%
from a methadone clinic; 4% from subject referrals; and
2% from Beth Israel Deaconess Medical Center.
Of 444 eligible subjects screened, 349 (79%) provided
informed consent to participate in the study. BecauseBMC Health Services Research 2006, 6:19 http://www.biomedcentral.com/1472-6963/6/19
Page 3 of 10
(page number not for citation purposes)
study subjects were recruited over a four-year period
(1997 to 2001), and all follow-ups ceased in August 2001,
time of recruitment was the major factor affecting the
number of follow-up observations in this study (P <
.0001) [26].
Those subjects receiving antiretroviral therapy at the time
of recruitment participated in a randomized controlled
trial to enhance adherence to antiretroviral therapy. The
intervention consisted of three nurse visits over a 3-month
period to problem-solve with the patient about ways to
decrease missed doses. The intervention was not signifi-
cantly associated with higher adherence [22].
The Institutional Review Boards of Boston Medical Center
and Beth Israel Deaconess Medical Center approved this
study.
Data collection
Subjects were interviewed up to 7 times over the study
period, approximately 6 months apart, from 1997 to
2001. At each scheduled interview, trained research asso-
ciates, using a standardized instrument in either English
or Spanish, obtained information about housing status,
medical service utilization, HIV risk behaviors, antiretro-
viral medication use, substance use, addiction severity,
and depressive symptoms. The Spanish interview instru-
ment used the standardized Spanish versions of scales
when available; the remainder of the questionnaire was
translated from English into Spanish, back translated to
check for accuracy, and then corrected. CD4 cell counts
and HIV RNA levels were collected, using existing labora-
tory tests if performed as part of clinical care within six
months of the interview. When clinical samples were una-
vailable, the Boston Medical Center Clinical Laboratory
evaluated blood samples collected for study purposes.
Outcome variables
Our three outcomes of interest were the number of self-
reported ambulatory visits, the number of emergency
department (ED) visits, and the number of hospitaliza-
tions in the 6 months prior to the research interview.
Main predictor variable
We used subjects' report of any night spent on the street or
in a shelter in the past 6 months to indicate an episode of
homelessness [27]. This was assessed with the survey
question, "In the last 6 months, how many nights have
you spent in an overnight shelter, or on the street, without
shelter?" Sleeping in environments intended for tempo-
rary shelter, or in places not meant for sleeping, corre-
sponds to the federal McKinney Act's definition of
homelessness and approximates "literal homeless-
ness"[28].
Other explanatory variables
We used the Behavioral Model for Vulnerable Populations
[29] as a conceptual framework to help guide our choice
of covariates for inclusion in the multivariable regression
models explaining health service use. Predisposing factors
(age, gender, race/ethnicity, housing status, substance
abuse severity, and depressive symptoms) and relevant
indicators of need for medical health service use (CD4 cell
count, HIV RNA viral load, receipt of any antiretroviral
therapy) were included in the models. Health insurance
status, an enabling/disabling factor, was measured but not
included in the models since 99% of all subjects had
access to private, Medicaid or a special publicly-funded
health insurance for medications, ambulatory and ED vis-
its, and hospitalizations. Substance abuse severity was
assessed with the alcohol and drug composite scores from
the Addiction Severity Index (ASI-alc and ASI-drug,
respectively), an assessment instrument with documented
reliability and validity, each scored 0–1, with higher
scores indicating increased severity [30]. Depressive
symptoms were measured with the 20-item Center for
Epidemiologic Studies Depression Scale (CES-D); scores ≥
16 are considered to reflect significant depressive symp-
toms [31]. Participation in the intervention trial and study
time point were also included as potential explanatory
variables.
Analysis
Descriptive statistics (proportions, means, standard devi-
ations) and univariate analyses were used to compare sub-
jects by housing status at baseline. Categorical variables
were compared using chi-square test and continuous var-
iables with the two-sample t-test. We calculated the pro-
portion of subjects experiencing homelessness over time
using a Kaplan-Meier survival estimator. Since we asked
about homelessness in the 6 months prior to each inter-
view, time 0 was considered to be 6 months prior to the
first interview, therefore the survival estimator calculated
the proportion of subjects experiencing homelessness
over 36 months.
To examine the association of homelessness and medical
service utilization, we constructed separate multivariate
longitudinal regression models for each outcome: ambu-
latory visits, ED visits, and hospitalizations. The unit of
analysis for regression models was by observation (e.g.
interview). Longitudinal regression models calculated
incidence rate ratios (IRR) for each available 6-month
observation period (homeless versus housed). Since serial
measures on the same individuals were collected, general-
ized estimating equation (GEE) regression models[32]
were used to adjust for the correlation between these
measures over time. We used an empirical working vari-
ance estimator in these models and log link function
(Poisson regression).BMC Health Services Research 2006, 6:19 http://www.biomedcentral.com/1472-6963/6/19
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In order to focus on the statistical significance of the
homelessness variable (any versus none), we used the
Behavioral Model for Vulnerable Populations to build
multivariate models with covariates, including predictor
variables that proved to not be significant. The following
variables were included in all models: age, gender, race/
ethnicity (2 df), study time point (6 df), CD4 cell count,
HIV RNA log10 viral load, receipt of antiretroviral therapy
(any or none) and participation in the antiretroviral
adherence intervention (adherence intervention group,
control group, and not on antiretroviral medication; 2 df).
To explore whether the statistical significance of home-
lessness was affected by inclusion of addiction severity
and depressive symptoms in the equations, models were
also constructed with variables for alcohol abuse severity
(ASI-alc score), drug abuse severity (ASI-drug score), and
any depressive symptoms (CES-D ≥ 16). All the predictor
variables were allowed to vary with time except for age,
gender, race/ethnicity, and intervention trial assignment
group.
We performed a secondary analysis to examine whether
there was a "dose-response" relationship between the
number of nights homeless and utilization differences.
We analyzed homelessness based upon the cumulative
number of nights homeless in a 6-month observation
period. The median number of nights homeless (i.e., 30)
and interquartile range (7,90) were used to define the 5-
level categorical homelessness variable.
All analyses were run using SAS statistical software version
8.2 [33].
Table 1: Demographic and Clinical Characteristics of Study Cohort (N = 349)Stratified by Housing Status at Baseline *
Categorical measures, % Homeless N = 101 Not homeless N = 248 p-value
Female 13 24 0.02
Race/ethnicity† 0.29
Black 38 47
Hispanic 26 21
White 37 32
High school graduate 49 65 0.005
Health insurance‡ 98 99.6 0.15
Prescribed antiretroviral medications§ 47 64 0.001
Physical injury§ 17 9 0.04
Physical or sexual abuse
Lifetime 78 82 0.40
Recent § 14 7 0.05
Jail § 36 26 0.05
Substance use||
Alcohol 45 42 0.60
Cocaine 21 25 0.36
Heroin 16 8 0.04
Continuous measures, N [std]
Age 40.8 [6.8] 40.5 [7.5] 0.70
CD4 cell count ¶ 405 [291] 399 [273] 0.90
HIV RNA (log10) ¶ 47K [95K] 26K [68K] 0.05
Depressive symptoms ** 27.2 [14.13] 20.2 [12.08] < 0.0001
Addiction Severity Index: ††
Alcohol composite score 0.25 [0.25] 0.18 [0.20] 0.009
Drug composite score 0.13 [0.12] 0.11 [0.10] 0.05
* The majority (56%)of study participants were recruited through from the Boston Medical Center HIV Diagnostic Evaluation Unit. The remaining 
from posted flyers 17%; Boston Medical Center Primary Care Clinic 13%; respite facility for homeless persons 5%; methadone clinic 4%; subject 
referrals 4%; and Beth Israel Deaconess Medical Center 2%.
† Categories are not mutually exclusive, so total number will >100%
‡ Private, Medicare, Medicaid, or special publicly funded health insurance for individuals with HIV-infection
§ Previous 6 months
||Previous 30 days
¶ Laboratory tests collected as part of clinical care were used if performed within six months of the interview. When clinical samples were 
unavailable, the Boston Medical Center Clinical Laboratory evaluated blood samples collected for study purposes.
** Depressive symptoms were measured with the 20-item the Center for Epidemiologic Studies Depression Scale
†† Range of possible scores 0–1 with a higher score indicating worse addiction severity.BMC Health Services Research 2006, 6:19 http://www.biomedcentral.com/1472-6963/6/19
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Results
Subject characteristics
Descriptive characteristics of the cohort (n = 349) strati-
fied by housing status reported at the first (baseline) inter-
view are presented in Table 1. Compared to housed
subjects, more of the subjects reporting homelessness at
baseline (101/349, 29%) were male, had not graduated
from high school, and had recently been incarcerated,
injured, or abused (either physically or sexually). In addi-
tion, homeless subjects endorsed significantly more
depressive symptoms on the CES-D (27.2 vs. 20.5, P <
.0001). While the mean CD4 cell count was not signifi-
cantly different between homeless and housed subjects
(405 vs. 399 cells/µl, respectively, P = .81), a lower pro-
portion of the homeless subjects reported taking any
antiretroviral medications in the previous 6 months com-
pared to the housed (47% vs. 64%, P = .001).
No difference was found in the proportion of subjects
who drank any alcohol. However, among those who
drank any alcohol, the homeless reported higher alcohol
consumption and alcohol abuse severity as reflected by
drinks per day (5.5 vs. 1.6, P = .03) and ASI-alcohol com-
posite score (P = .009). While no difference was found in
cocaine use (21% vs. 25%, P = .36), a higher proportion
of the homeless reported any heroin use (16% vs. 8%, P =
.04), and higher drug abuse severity as measured by the
ASI-drug composite score (P = .05).
Forty-two percent (148/349) of the cohort had a history of
homelessness in the 5 years before entering the study
(median duration 6 months, interquartile range 3 to 18
months). As mentioned previously, 29% of the cohort
reported homelessness at the baseline interview. The
median number of nights homeless in the 6 months
before the baseline interview was 30 nights with inter-
quartile range of 7 and 120 (possible range 0–180). By the
end of 36 months of observation, 39% (136/349) of the
study cohort reported homelessness at least once in the
preceding 6 months.
Using all observations (n = 1045), medical service utiliza-
tion during a 6-month period is summarized as follows
(median, 75% quartile, range): ambulatory visits (4, 7, 0–
180); ED visits (0, 1, 0–15); and hospitalizations (0, 0,
range 0–10).
Table 2: Multivariable Longitudinal Regression Results of Predictors of Medical Service Utilization Among Adults with HIV Infection 
and Alcohol Problems (n= 1045 observations)
IRR† (95% CI)
Ambulatory Emergency Room Hospitalization
Age 1.01 (1.00, 1.03) 1.00 (0.98, 1.01) 1.02 (1.00, 1.04)
Female 1.44 (1.11, 1.87)* 1.50 (1.11, 2.03)** 1.64 (1.11, 2.42)*
Race/ethnicity
Black 0.86 (0.68, 1.08) 0.99 (0.74, 1.31) 1.30 (0.87, 1.92)
Hispanic 0.63 (0.50, 0.77)*** 0.81 (0.56, 1.18) 0.73 (0.44, 1.23)
W h i t e 111
Lower CD4 cell count ‡ 1.05 (1.01–1.10)* 1.07 (0.98, 1.20) 1.10 (1.03, 1.16)**
HIV RNA viral load log10 1.00 (0.94, 1.05) 1.00 (0.94, 1.07) 1.01 (0.92, 1.10)
Antiretroviral medication use 1.06 (0.86, 1.31) 0.91 (0.72, 1.15) 1.00 (0.72, 1.39)
Adherence intervention randomization assignment
Intervention group 1.28 (1.01, 1.62)* 1.11 (0.82, 1.51) 1.46 (0.99, 2.16)
Control group 1.32 (1.04, 1.68)* 0.88 (0.65, 1.19) 1.07 (0.73, 1.57)
Not a participant § 111
Alcohol addiction severity (ASI-alcohol)|| 1.92 (1.25, 2.94)** 1.13 (0.67, 1.93) 1.54 (0.69, 3.44)
Drug addiction severity (ASI-drug) || 1.47 (0.59, 3.64) 2.29 (0.87, 6.06) 4.38 (1.18, 16.33)*
Depressive symptoms (CES-D) 1.01 (1.00, 1.01) 1.02 (1.01, 1.03) ** 1.02 (1.01, 1.03)***
Homelessness (any versus none) 1.10 (0.91, 1.32) 1.95 (1.55, 2.45)*** 1.90 (1.41, 2.57)***
* P < 0.05
** P < 0.05
*** P < 0.005
† IRR: incidence rate ratio of medical service utilization for 6-month observation period in which homelessness is reported compared to intervals 
without homelessness. Separate multivariate regression models were constructed for each utilization outcome. Later study time point was 
associated with lower ambulatory visit utilization rates (df 6, P = 0.003) and lower hospitalization utilization rates (6 df, P = .05). Study time point 
was not significantly associated with emergency room utilization rate differences.
‡ Per 100 reduction in CD4 cell count
§ Subjects not receiving antiretroviral medications did not participate in the adherence intervention study.
|| Per one point higher scoreBMC Health Services Research 2006, 6:19 http://www.biomedcentral.com/1472-6963/6/19
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Medical service utilization and homelessness
Ambulatory visits
No significant difference was found in ambulatory visit
utilization between homeless and housed periods in the
multivariate longitudinal regression model (IRR 1.09;
95% CI 0.89–1.33). Adjusting for alcohol, drug abuse and
depressive symptoms did not markedly change these find-
ings (IRR 1.10; CI 0.91–1.32). Other factors associated
with higher ambulatory visit utilization included: female
gender (IRR 1.44; CI 1.11–1.87), less severe alcohol abuse
(IRR 1.92; CI 1.25–2.94 per one point reduction in ASI-
alcohol composite score), and lower CD4 cell count (IRR
1.05; CI 1.01–1.10 per 100 reduction in cell count/µl),
earlier study time point (df 6, P = 0.003), and participa-
tion in the antiretroviral adherence intervention (df 2, P
0.04). Identifying as Hispanic, however, was associated
with lower ambulatory visit utilization (IRR 0.63; CI 0.50,
0.77).
Emergency department
Homelessness was significantly associated with greater
use of the ED (IRR 2.17; CI 1.72–2.74). This finding was
slightly attenuated but remained significant when adjust-
ing for alcohol, drug abuse and depressive symptoms (IRR
1.95; CI 1.55–2.45). As presented in Table 3, one to seven
homeless nights were not associated greater use of the ED
(IRR 1.31; 0.85–2.15). However, there were significant
associations between a higher number of nights of home-
lessness (8–30, 31–120, and 121–180 nights) and ED uti-
lization rates (IRR 1.49, 2.17, and 2.65, respectively).
Other significant predictors of higher ED utilization were
female gender (IRR 1.50; CI 1.11–2.03) and more depres-
sive symptoms (IRR 1.02; CI 1.01–1.03 per one point
increase in CES-D score).
Hospitalization
Homelessness was also significantly associated with inpa-
tient hospitalizations (IRR 2.30; CI 1.70–3.12). This find-
ing was attenuated but remained significant after
adjusting for alcohol, drug abuse severity and depressive
symptoms (IRR 1.90; CI 1.41–2.56). Similar to the analy-
ses of ED utilization rates, one to seven days of homeless-
ness were not associated with hospitalization rate
differences. However, hospitalization rate differences
were found with 8 to 30 nights homeless (IRR 1.85; 1.17–
2.94), 31–120 nights (IRR 1.85; 1.17–2.94) and 121 to
180 nights (IRR 2.88; 1.95–4.25). Other factors signifi-
cantly associated with higher hospital utilization rates
included: lower CD4 cell count (IRR 1.10; CI 1.03–1.16
per 100 reduction in cell count/µl); worse drug abuse
severity (IRR 4.38; CI 1.18–16.33 per 1 point increase in
ASI-drug composite score), more depressive symptoms
(IRR 1.02; CI 1.01–1.03 per one point increase in CES-D
score), and earlier study time point (6 df, P = .05).
Discussion
In this prospective cohort study of individuals with HIV
infection and alcohol problems, utilization of ED and
hospital inpatient care was significantly higher during
periods in which homelessness was experienced. In addi-
tion, greater ED and hospital inpatient utilization differ-
ences were found with more nights homeless. These
utilization findings were not fully attributable to addic-
tion severity or depressive symptoms.
This study's findings are consistent with prior findings
that homelessness is associated with higher ED visits
[9,13] and hospitalizations [8,34] in individuals with HIV
infection. Prior work, however, was unable to disentangle
the simultaneous effects of addiction disorders and
depressive symptoms, both of which are known to predict
physical functioning in homeless HIV-infected individu-
als [40] and hypothetically could contribute to higher ED
and inpatient utilization. Increased use of ED and hospi-
tal inpatient services during homeless periods may have
occurred for exposure-related conditions [35] or injuries
Table 3: Multivariable Longitudinal Regression Results of the Cumulative Number Nights Homeless and Medical Service Utilization 
(n= 1045 observations).
IRR† (95% CI)
Number nights homeless Ambulatory Emergency Room Hospitalization
01 1 1
1–7 1.24 (0.90, 1.71) 1.31 (0.80, 2.15) 1.07 (0.64, 1.80)
8–30 1.15 (0.84, 1.57) 1.49 (1.02, 2.19)* 1.83 (1.01, 3.32)*
31–120 1.27 (0.97, 1.67) 2.17 (1.54, 3.07) * 1.85 (1.17, 2.94)**
121–180 0.79 (0.61, 1.03) 2.65 (1.94, 3.61) *** 2.88 (1.95, 4.25) ***
† IRR: incidence rate ratio of medical service utilization for 6-month observations periods Separate multivariate regression models were used for 
each utilization outcome. All models include age, gender, race/ethnicity (2 df), CD4 cell, HIV RNA viral load log10, antiretroviral medication use, 
adherence intervention participation, presence of depressive symptoms (Center for Epidemiologic Studies Depression Scale), and addiction severity 
(Addiction Severity Index, alcohol and drug composite scores).
‡ Number nights homeless was defined by the survey question, "In the last six months, how many nights have you spent in an overnight shelter, on 
the street, without shelter?" Homelessness was categorized based upon the median nights homeless for the sample (i.e., 30) and interquartile range 
(i.e., 7, 120).BMC Health Services Research 2006, 6:19 http://www.biomedcentral.com/1472-6963/6/19
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due to victimization [36]. Even though no difference was
found in ambulatory utilization, it remains plausible that
the daily struggle to meet basic subsistence needs may
have been a barrier to accessing outpatient care in a timely
manner (e.g. earlier in the course of an acute illness)
[4,37] resulting in ED visits or hospitalizations.
It is important to note that this study modeled homeless-
ness as a time varying "state" rather than a "trait". A sub-
ject could contribute to utilization incidence rates for the
homeless cohort and subsequently to the housed compar-
ison group if that subject did not experience any home-
lessness in another interview period. This approach
suggests that the state of homelessness contributes to
higher hospitalizations and ED utilization, rather than
unique features of the "homeless" person. Although cau-
sality cannot be proven [38], the finding that a higher
number of nights homeless was associated with greater
ED and hospitalization differences suggests that home-
lessness contributes to these utilization differences.
A substantial minority of 29% reported homelessness
during the 6 months prior to the baseline interview and
39% at any time during the study period. The proportion
of homeless subjects in this study likely reflects selective
inclusion of HIV-positive persons with a history of alco-
hol problems. This cohort's higher incidence of homeless-
ness compared to published reports (6 to 11%) [3,8,13]
results, in part, from this study's longitudinal study
design, which was more likely to capture both the long-
term homeless and persons homeless for short periods of
time (i.e. the transiently and episodically homeless)[20].
Since a pattern of intermittent access to conventional
housing is relatively common among homeless persons
[39], cross-sectional studies tend to over-sample chroni-
cally homeless persons [7]. Perhaps more importantly,
since many of the patients in this study were at-risk for
homelessness for a variety of reasons (e.g., low income,
recent incarceration, depressive symptoms, and alcohol or
drug addiction) residential instability could have resulted
from the worsening of just one of these factors for individ-
uals without much of a safety net.
Although previous studies have documented less ambula-
tory care utilization among homeless persons [9,13], we
did not find such a difference between homeless and
housed periods. We postulate that this may have been due
to a recruitment strategy that drew predominantly from
an HIV intake clinic that facilitated primary care linkage
[25] as well as access to health insurance in a state that
aggressively expanded Medicaid during the study period.
There are several important implications for our findings.
First, to the extent that an investment in housing and
other services to prevent homelessness among HIV-
infected persons would require a major allocation of pub-
lic resources, the cost of not adopting such a strategy
needs to be clarified [40]. Studies of service utilization by
severely mentally ill homeless persons suggest that hous-
ing costs can be offset by savings realized from hospitals
and jails, [41] however similar evaluations of housing
HIV-infected persons are lacking.
Second, since this study occurred in a city with relatively
generous ambulatory care services for the homeless, an
even greater use of ED and inpatient hospital services
might be expected in settings where ambulatory care for
homeless persons is less accessible [42]. Furthermore,
since homeless periods were not associated with lower
ambulatory utilization in our sample (perhaps reflecting
local supply of these services), it seems unlikely that fur-
ther expansion of homeless ambulatory care programs
would fully address excess ED and hospital utilization. To
the extent that statistical adjustments for substance abuse
severity minimally altered the effects of homelessness,
expanded access to addiction treatment services alone
may not be sufficient to mitigate intensive medical utiliza-
tion patterns.
Our study has several limitations. While it would have
been ideal to have a night-by-night account of when
homelessness and medical service utilization occurred,
our data collection precluded determination of whether
homeless nights were concurrent with dates of medical
service utilization. Additionally, our objective indicators
of medical need (CD4 cell count, HIV viral load, and
antiretroviral medication use) may not have fully encom-
passed physical health, since co-morbid conditions have
been increasingly recognized for their impact on HIV-
infected individuals [43] and may have contributed to uti-
lization differences. Also, medical service utilization was
determined by self-report. However, studies have found
self-reported health care use to be a valid measure among
HIV-infected individuals [44], homeless persons [45], and
drug users [46]. Homeless persons are a heterogeneous
population, yet we did not differentiate among subgroups
that have varying utilization patterns such as the unshel-
tered or the chronically homeless [47,48]. Also, we exam-
ined a subsample of individuals with HIV/AIDS and
unstable housing, namely those with a history of alcohol
problems. Our findings may not apply to homeless, HIV-
infected individuals without a history of alcohol prob-
lems. The data was taken from a randomized trial of an
antiretroviral adherence intervention. However, participa-
tion in the intervention was not associated with ED or
hospitalization differences. Finally, while we did not find
differential utilization of ambulatory care services accord-
ing to housing status, the number of ambulatory visits
does not capture important information such as longitu-
dinal provider continuity across visits and the provision ofBMC Health Services Research 2006, 6:19 http://www.biomedcentral.com/1472-6963/6/19
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integrated case management services. Both have been
associated with lower utilization of ED and hospitaliza-
tions in other studies [4,49].
The strengths of this study include its careful assessment
of alcohol, drug abuse, and depressive symptoms, infor-
mation frequently missing in other research on utilization
in the homeless HIV-infected. Moreover, its longitudinal
nature allowed examination of the episodically homeless
persons, a group underrepresented in cross-sectional
homeless studies [50].
In summary, in HIV-infected persons with alcohol prob-
lems, homelessness was associated with higher utilization
of ED and inpatient hospitalizations, despite no differ-
ence in ambulatory visit utilization. These utilization dif-
ferences were not fully attributable to alcohol, drug abuse
or depressive symptoms. Even a transient episode of
homelessness has potentially costly implications for
health care utilization among HIV-infected persons with a
history of alcohol abuse.
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